SPECIAL COMMUNICATIONS: Book Reviews
ISBN: 978-1-60761-684-9. Edition: 1st. Author: Kewal K. Jain, MD. Specialties: Biochemistry, Pharmacology. Publisher: Humana Press Inc. List Price: $199.00
This is a comprehensive overview of known biomarkers, technologies used in their identification, as well as the relevance of these biomarkers to clinical diagnostics and drug development.
Currently, there is a wealth of information pertaining to biomarkers, yet a single comprehensive reference does not exist. This handbook represents a detailed guide to different biomarkers and their roles in predicting and diagnosing various diseases.
Individuals participating in basic research or clinical applications relating to biomarkers as well as those involved in drug discovery and development processes.
Comprehensive and cutting-edge, The Handbook of Biomarkers serves as a vital guide to furthering our understanding of biomarkers by facilitating the combination of therapeutics with diagnostics, which promise to play an important role in the development of personalized medicine, an emerging trend in health care. The handbook consolidates the vast literature regarding biomarkers, presenting it first on the basis of the technologies used to discover biomarkers and second on the basis of biomarker relevance to health care. The scope of disease states and the depth to which each is covered is exhaustive, engaging readers with information on numerous pathologies including immune, muscle, liver, kidney, neurological disorders, and cancer.
This book fulfills the need for a single, comprehensive guide to the discovery, validation, and application of various biomarkers. Although readers may find some subsets of these biomarkers described in other books, it targets a broader range of biomarkers, highlights innovative technologies used in the discovery of these biomarkers, and addresses the potential application of biomarkers in personalized medicine. The author has published numerous articles on the topics addressed in this book including, but not limited to, personalized medicine, oncoproteomics, and state-of-the-art diagnostic technologies. The illustrations are sufficient, of high quality, and are pedagogically valuable.
Reviewed by: Rachel Chennault, PhD (University of Kansas Medical Center, Kansas City, KS)